Related Experiment Videos
Exploring glia to better understand Alzheimer's disease
Yoo Sung Kim1, Hae Myeong Jung1, Bo-Eun Yoon1
1Department of Molecular Biology, Dankook University, Cheonan, Korea.
Animal Cells and Systems
|November 22, 2018
Summary
Alzheimer's disease (AD) involves amyloid-beta (Aβ) accumulation. This review examines the dual neuroprotective or neurotoxic roles of microglia and astrocytes in AD pathogenesis and treatment.
Area of Science:
- Neuroscience
- Immunology
- Pathology
Background:
- Alzheimer's disease (AD) pathogenesis is often explained by the amyloid-beta (Aβ) hypothesis.
- Aβ accumulation causes cognitive decline and memory loss, activating glial cells for Aβ clearance.
- While microglia have been the focus, astrocytes also play crucial roles in brain immunity and homeostasis.
Purpose of the Study:
- To review the complex roles of both microglia and astrocytes in Alzheimer's disease.
- To explore the neuroprotective versus neurotoxic functions of glial cells in AD.
- To identify potential novel therapeutic targets for AD treatment.
Main Methods:
- Literature review of studies on glial cells (microglia and astrocytes) in Alzheimer's disease.
- Analysis of research investigating the mechanisms of Aβ aggregation and glial cell activation.
- Synthesis of findings on the dual roles of glial cells in AD pathogenesis.
Main Results:
- Glial cells, including microglia and astrocytes, are activated by Aβ aggregates.
- Evidence suggests both neuroprotective and neurotoxic functions for microglia and astrocytes in AD.
- The precise role of each glial cell type in AD progression remains debated.
Conclusions:
- Both microglia and astrocytes are implicated in Alzheimer's disease pathogenesis.
- Understanding the nuanced functions of these glial cells is critical for developing effective AD therapies.
- Further research is needed to elucidate the specific contributions of microglia and astrocytes to neurodegeneration and identify targeted treatments.